1727 related articles for article (PubMed ID: 27581448)
1. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
2. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
3. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
[TBL] [Abstract][Full Text] [Related]
4. Enriched environment enhances β-adrenergic signaling to prevent microglia inflammation by amyloid-β.
Xu H; Rajsombath MM; Weikop P; Selkoe DJ
EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30093491
[TBL] [Abstract][Full Text] [Related]
5. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.
Latta CH; Sudduth TL; Weekman EM; Brothers HM; Abner EL; Popa GJ; Mendenhall MD; Gonzalez-Oregon F; Braun K; Wilcock DM
J Neuroinflammation; 2015 Mar; 12():41. PubMed ID: 25885682
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
Wu PJ; Hung YF; Liu HY; Hsueh YP
Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
[TBL] [Abstract][Full Text] [Related]
7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
8. Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
Sanchez-Mejias E; Navarro V; Jimenez S; Sanchez-Mico M; Sanchez-Varo R; Nuñez-Diaz C; Trujillo-Estrada L; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Acta Neuropathol; 2016 Dec; 132(6):897-916. PubMed ID: 27743026
[TBL] [Abstract][Full Text] [Related]
9. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
[TBL] [Abstract][Full Text] [Related]
10. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
[TBL] [Abstract][Full Text] [Related]
12. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
13. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
14. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
[TBL] [Abstract][Full Text] [Related]
15. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
[TBL] [Abstract][Full Text] [Related]
16. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
17. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M
J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912
[TBL] [Abstract][Full Text] [Related]
18. Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
Wang E; Zhu H; Wang X; Gower AC; Wallack M; Blusztajn JK; Kowall N; Qiu WQ
J Alzheimers Dis; 2017; 56(1):47-61. PubMed ID: 27911303
[TBL] [Abstract][Full Text] [Related]
19. Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice.
Stuart KE; King AE; King NE; Collins JM; Vickers JC; Ziebell JM
Neuroscience; 2019 Jun; 408():282-292. PubMed ID: 30999032
[TBL] [Abstract][Full Text] [Related]
20. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.
Cameron B; Tse W; Lamb R; Li X; Lamb BT; Landreth GE
J Neurosci; 2012 Oct; 32(43):15112-23. PubMed ID: 23100432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
